Role of Notch-1/PLA2-IIA in oral dysbiosis, inflammation, and periodontal disease
Notch-1/PLA2-IIA 在口腔生态失调、炎症和牙周病中的作用
基本信息
- 批准号:10447008
- 负责人:
- 金额:$ 54.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdverse effectsAgreementAnimal ModelAntimicrobial EffectAntimicrobial susceptibilityApoptosisAutophagocytosisBacteriaCell ProliferationCell physiologyCellsClinicalComplexDataDevelopmentDiseaseEcologyEnzymesEpithelialEpithelial CellsEventExhibitsFirmicutesGene ExpressionGingivaHealthHumanImmuneIn VitroInbred BALB C MiceInfectionInflammationInflammatoryKnowledgeLeadLesionMediatingMicrobeModelingMolecularMouse StrainsMucosal ImmunityMucous MembraneMusMutationNatural ImmunityOralOral healthPLA2G2A genePathogenicityPathway interactionsPeriodontal DiseasesPeriodontitisPhospholipase A2PlayPorphyromonas gingivalisPropertyProteobacteriaPublic HealthReceptor ActivationReportingResearchResearch DesignResistanceRoleSurfaceTestingTimeTransgenic MiceVariantadaptive immunityantimicrobialbasebone losschemokinechronic infectionchronic inflammatory diseasedysbiosisgingipainin vivoinnovationmacrophagemalignant mouth neoplasmmicrobialmicrobial communitymicrobiotamouse modelnonhuman primatenotch proteinoral cavity epitheliumoral microbiomeoral pathogenoverexpressionpathogenpreventreceptorrecruitresponse
项目摘要
The mechanisms by which mucosal responses to the microbiota in the presence of specific pathogenic bacterial
species (e.g. P. gingivalis-Pg), could abrogate the host-microbe symbiotic relationship leading to dysbiosis and
inflammatory disease remain not fully understood. Our pioneering R21 studies demonstrated that Pg-induced
phospholipase A2 group IIA (PLA2-IIA), in a mechanism that involves activation of Notch-1 receptor (N1R) by
Pg gingipains, modulates the antimicrobial properties of oral epithelial cells (OECs). This is consistent with in
vivo and clinical evidence supporting the potent (ng/mL) antimicrobial effects of PLA2-IIA. Noteworthy, oral
bacterial species exhibited differential antimicrobial susceptibility to PLA2-IIA. Moreover, gingival PLA2-IIA
expression and N1R activation were elevated during initiation and progression of periodontal disease, which was
concurrent with oral dysbiosis in non-human primates. In agreement with these observations, new preliminary
studies using mice models demonstrated increased gingival PLA2-IIA expression and N1R activation early after
Pg infection. Remarkably, the oral microbiome of transgenic mice overexpressing PLA2-IIA (PLA2-IIA-Tg)
exhibited significant differences in the abundance of bacterial species (decreased Firmicutes and increased
Proteobacteria) compared to their wild type co-caged littermates. Oral dysbiosis in PLA2-IIA-Tg mice was
associated with changes in the gingival expression of genes involved in intracellular sensing (NOD2), classical
antimicrobial factors (S100a8/S100a9, hBD1), and M1/M2 macrophage chemokines. N1R is a critical modulator
of mucosal immunity; therefore, the ability of Pg to activate N1R in OECs is an exciting and innovative
observation. Preliminary data suggested that other OEC functions/responses (bacterial sensing, apoptosis, and
autophagy) could involve Pg-induced N1R activation. Based on this evidence, we hypothesize that activation of
Notch-1/PLA2-IIA pathway in gingival epithelial surfaces would be an innovative and plausible mechanism by
which pathogens such as Pg could specifically enhance oral dysbiosis, inflammation and periodontal disease. To
test this hypothesis, we propose three specific aims: (i) To determine the role of PLA2-IIA in Pg-induced
oral dysbiosis, inflammation and periodontal disease, (ii) To determine the role of epithelial
Notch-1 in Pg-induced PLA2-IIA and periodontitis, and (iii) To identify and validate oral
epithelial innate responses modulated by Pg through Notch-1 activation. To address these
knowledge gaps, we will use the Pg-induced periodontitis oral gavage model in mouse strains with or without a
natural PLA2-IIA mutation, PLA2-IIA-Tg mice with their WT littermates, epithelial-specific N1R deficient mice,
as well as OEC cultures to validate the role of this pathway in Pg-induced oral dysbiosis and periodontal disease.
These findings will enable a better understanding of the cellular and molecular mechanisms that are specifically
modulated by pathogens to alter microbial communities at mucosal surfaces as well as contribute to the evidence
for future research designed to determine the role of N1R in oral health and other diseases (e.g., oral cancer).
在特定病原菌存在的情况下,粘膜对微生物群的反应机制
种(例如 P. gingivalis-Pg),可能会破坏宿主与微生物的共生关系,导致菌群失调和
炎症性疾病仍未完全了解。我们开创性的 R21 研究表明,Pg 诱导
磷脂酶 A2 IIA 组 (PLA2-IIA),其机制涉及通过激活 Notch-1 受体 (N1R)
Pg gingipains 可调节口腔上皮细胞 (OEC) 的抗菌特性。这与在
体内和临床证据支持 PLA2-IIA 的有效 (ng/mL) 抗菌作用。值得注意的是,口头
细菌种类对 PLA2-IIA 表现出不同的抗菌敏感性。此外,牙龈PLA2-IIA
在牙周病的发生和进展过程中,N1R 的表达和激活水平升高,
与非人类灵长类动物的口腔生态失调同时发生。与这些观察一致,新的初步
使用小鼠模型的研究表明,术后早期牙龈 PLA2-IIA 表达和 N1R 激活增加
PG感染。值得注意的是,转基因小鼠的口腔微生物组过度表达 PLA2-IIA (PLA2-IIA-Tg)
细菌种类丰度存在显着差异(厚壁菌门减少,而细菌种类增加)
变形菌)与其野生型同笼同窝动物相比。 PLA2-IIA-Tg 小鼠的口腔生态失调
与细胞内传感 (NOD2) 相关基因的牙龈表达变化相关,经典
抗菌因子(S100a8/S100a9、hBD1)和 M1/M2 巨噬细胞趋化因子。 N1R 是一个关键的调制器
粘膜免疫;因此,Pg 激活 OEC 中 N1R 的能力是令人兴奋和创新的
观察。初步数据表明其他 OEC 功能/反应(细菌感应、细胞凋亡和
自噬)可能涉及 Pg 诱导的 N1R 激活。基于这一证据,我们假设激活
牙龈上皮表面的 Notch-1/PLA2-IIA 通路将是一种创新且合理的机制
Pg等病原体可以特异性增强口腔生态失调、炎症和牙周病。到
为了检验这一假设,我们提出了三个具体目标:(i) 确定 PLA2-IIA 在 Pg 诱导中的作用
口腔生态失调、炎症和牙周病,(ii) 确定上皮细胞的作用
Pg 诱导的 PLA2-IIA 和牙周炎中的 Notch-1,以及 (iii) 识别和验证口腔
Pg 通过 Notch-1 激活调节上皮先天反应。为了解决这些
由于知识差距,我们将在有或没有牙周炎的小鼠品系中使用 Pg 诱导的牙周炎口服灌胃模型。
天然 PLA2-IIA 突变、PLA2-IIA-Tg 小鼠及其 WT 同窝小鼠、上皮特异性 N1R 缺陷小鼠、
以及 OEC 培养物,以验证该途径在 Pg 诱导的口腔生态失调和牙周病中的作用。
这些发现将有助于更好地理解特定的细胞和分子机制。
受病原体调节以改变粘膜表面的微生物群落并有助于证据
用于未来旨在确定 N1R 在口腔健康和其他疾病(例如口腔癌)中的作用的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Octavio Alberto Gonzalez其他文献
Octavio Alberto Gonzalez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Octavio Alberto Gonzalez', 18)}}的其他基金
Role of Notch-1/PLA2-IIA in oral dysbiosis, inflammation, and periodontal disease
Notch-1/PLA2-IIA 在口腔生态失调、炎症和牙周病中的作用
- 批准号:
10615876 - 财政年份:2021
- 资助金额:
$ 54.4万 - 项目类别:
Modulation of innate epithelial cell responses by oral commensal bacteria
口腔共生细菌调节先天上皮细胞反应
- 批准号:
8967461 - 财政年份:2015
- 资助金额:
$ 54.4万 - 项目类别:
Antimicrobial and inflammatory epithelial responses modulated by P. gingivalis-induced PLA2-IIA
牙龈卟啉单胞菌诱导的 PLA2-IIA 调节抗菌和炎症上皮反应
- 批准号:
8806351 - 财政年份:2014
- 资助金额:
$ 54.4万 - 项目类别:
ONTOGENY OF INNATE IMMUNE RESPONSES AT MUCOSAL SURFACES
粘膜表面先天免疫反应的个体发生
- 批准号:
8360732 - 财政年份:2011
- 资助金额:
$ 54.4万 - 项目类别:
ONTOGENY OF INNATE IMMUNE RESPONSES AT MUCOSAL SURFACES
粘膜表面先天免疫反应的个体发生
- 批准号:
8168485 - 财政年份:2010
- 资助金额:
$ 54.4万 - 项目类别:
相似国自然基金
儿童药品不良反应主动监测中时序处理策略的方法学研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
- 批准号:82274368
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
- 批准号:82273739
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Community-based Medication Adherence Support for Older Adults Living with HIV and Hypertension (CBA Intervention)
为感染艾滋病毒和高血压的老年人提供基于社区的药物依从性支持(CBA 干预)
- 批准号:
10752723 - 财政年份:2023
- 资助金额:
$ 54.4万 - 项目类别:
Design and implementation of a social cognitive theory-based medication adherence coaching intervention
基于社会认知理论的药物依从性辅导干预的设计与实施
- 批准号:
10644251 - 财政年份:2023
- 资助金额:
$ 54.4万 - 项目类别:
Phase 1 Translational Diabetes Research Using The DYRK1A inhibitor, Harmine
使用 DYRK1A 抑制剂 Harmine 进行的 1 期转化糖尿病研究
- 批准号:
10665783 - 财政年份:2022
- 资助金额:
$ 54.4万 - 项目类别:
Development and Commercialization of a pupillometer to predict postoperative opioid-induced respiratory depression in children
用于预测儿童术后阿片类药物引起的呼吸抑制的瞳孔计的开发和商业化
- 批准号:
10390249 - 财政年份:2022
- 资助金额:
$ 54.4万 - 项目类别:
Vertical Sleeve Gastrectomy for Treatment of NASH: a pilot randomized control
垂直袖状胃切除术治疗 NASH:试点随机对照
- 批准号:
10450031 - 财政年份:2021
- 资助金额:
$ 54.4万 - 项目类别: